GAD2 and COVID-19: The autoantibodies identified in neuropsychiatric patients with COVID-19 and PCS are ARHGAP31, GAD65, acethylcholine receptor, D1/2, MOG, NMDAR, MCTP1, Yo, myelin, and Ma/Ta2.